Skip to main content
. 2024 May 11;13(9):e7168. doi: 10.1002/cam4.7168

TABLE 2.

Prior treatments.

N = 459
Prior surgery, n (%) 342 (76.5)
Missing 12
Prior radiation therapy, n (%) 370 (81.7)
Missing 6
Number of metastatic treatment lines, n (%)
2 97 (21.1)
3 90 (19.6)
4 65 (14.2)
5 67 (14.6)
≥ 6 140 (30.5)
Median (range) 4 (2–22)
Prior treatment for metastatic disease, n (%)
Trastuzumab 458 (99.8)
Trastuzumab emtansine 435 (94.8)
Pertuzumab 364 (79.3)